Difficulty: Medium
Average Score: 67%
Practice
A patient with diabetes insipidus is treated with nasal desmopressin acetate (DDAVP). The nurse determines that the drug is not having an adequate therapeutic effect when the patient experiences
Correct answer
B
Rationale
In this scenario, the correct answer is B) A urine specific gravity of 1.002. Desmopressin acetate (DDAVP) is a synthetic form of vasopressin used to treat diabetes insipidus by promoting water reabsorption in the kidneys. A urine specific gravity of 1.002 indicates that the urine is too dilute, suggesting that the medication is not working effectively to concentrate the urine.
Option A) Headache and weight gain are not indicative of desmopressin acetate's therapeutic effect but could be side effects of the medication or other factors.
Option C) Nasal irritation and nausea are common side effects of nasal desmopressin administration and do not necessarily indicate the medication's therapeutic effectiveness.
Option D) An oral intake greater than urinary output would be expected in a patient with diabetes insipidus who is responding well to desmopressin acetate as the medication helps to reduce excessive urination and fluid loss.
Educationally, understanding the expected therapeutic effects of medications used in endocrine disorders is crucial for nurses to assess and manage patients effectively. Monitoring urine specific gravity is a key aspect of evaluating the response to desmopressin acetate therapy in patients with diabetes insipidus. This knowledge helps nurses provide safe and quality care to patients with endocrine conditions.
Option A) Headache and weight gain are not indicative of desmopressin acetate's therapeutic effect but could be side effects of the medication or other factors.
Option C) Nasal irritation and nausea are common side effects of nasal desmopressin administration and do not necessarily indicate the medication's therapeutic effectiveness.
Option D) An oral intake greater than urinary output would be expected in a patient with diabetes insipidus who is responding well to desmopressin acetate as the medication helps to reduce excessive urination and fluid loss.
Educationally, understanding the expected therapeutic effects of medications used in endocrine disorders is crucial for nurses to assess and manage patients effectively. Monitoring urine specific gravity is a key aspect of evaluating the response to desmopressin acetate therapy in patients with diabetes insipidus. This knowledge helps nurses provide safe and quality care to patients with endocrine conditions.